Loading
Dayton Physicians Network
See Your Chart Online Bill Payment

2015 NCCN Guidelines for Patients: Multiple Myeloma

Updated resource for patients with Multiple Myeloma

The National Comprehensive Cancer Network patient resource 2015 NCCN Patient Guidelines: Multiple Myeloma is now available. The updated version includes important changes to the recommended therapy options and combinations sections in the treatment guide.  This guide also provides basic multiple myeloma information such as tests for myeloma, overview of treatments and a treatment guide. Be sure to also take a look at look at the NCCN Quick Guide for Multiple Myeloma, this resource summarizes all the key points of the Multiple Myeloma Guidelines.

Multiple Myeloma (sometimes simply called myeloma) is a cancer of the blood. It starts in a white blood cell called a plasma cell. Plasma cells are there to help fight infections. Myeloma causes the cancer cells to group together in the bone marrow, where they crowd out healthy cells.

While multiple myeloma is a relatively uncommon cancer, in 2015 there are expected to be about 26,850 new cases diagnosed in the United States.
Dayton Physicians Network offers treatment and support for multiple myeloma. We know that you want to receive the best possible treatment, compassionate care and to have it all available at convenient locations near where you live and work so we’re here for you.

 

Dayton Physicians Network encourages all cancer patients to get the facts about their disease. National Comprehensive Cancer Network is one of many reliable resources with information about myeloma and all other types of cancer.

We’re here for you, ensuring you have the latest treatment information.

Alpha Blockers and Kidney Stones

David W. Key, MD

 

 

 

 

 

 

 

According to the latest study in Urology Times- July 27, 2015  patients may benefit from treatment with tamsulosin, an alpha blocker for larger kidney stones.

At Dayton Physicians Network we stay informed and we want you to be informed too.  You can count on us to know the latest tests, technologies and treatments.

 

We’re here for you.

Dayton’s First MRI Ultrasound Fusion Guided Prostate Biopsy

David W. Key, MD
Mark-Monsour-MD

 

 

 

 

 

 

Dayton Physicians Network urologists perform first-ever MRI ultrasound fusion guided prostate biopsies in the Miami Valley area

 

We are proud to offer the MRI ultrasound fusion guided prostate biopsy, the first major advancement in prostate biopsies in 25 years. This technology is only one part of Dayton Physicians Network’s initiative to provide advanced technology and better clinical outcomes for diagnosis and treatment of prostate cancer in the Miami Valley.  Dayton Physicians Network-Urology is the only practice in the Miami Valley region to offer this cutting-edge procedure.

Prostate biopsies are used to diagnose or exclude cancer as a diagnosis in an estimated one million times per year in the US. Nearly all biopsies have been done using the conventional transrectal ultrasound or TRUS method. This technique allowed for tissue cores to be obtained under ultrasound guidance. The TRUS technique proved to be more accurate than prior methods where doctors used their examining finger to guide the needle. TRUS biopsies may easily miss small, early stage tumors due to lack of necessary image quality needed to detect tumors with reasonable accuracy.

Until now, the only tool available to diagnose relevant prostate cancer was the TRUS technique and while that procedure still works well for the majority of patients, in particular instances our patients will benefit from MRI ultrasound fusion guided biopsy.

 

What is MRI ultrasound fusion guided biopsy

Dr. Monsour recently described the procedure on our web page Reading Room. “Although MRI of prostate has been available for years; 3TMRI is now available, which provides better resolution. Using this MRI, a multiparametric MRI can be performed to better identify lesions that may represent prostate cancer. Then a fusion biopsy is performed. Fusing MRI images with real time transrectal ultrasound so that both targeted and systematic biopsies can be performed. This results in a higher degree of accuracy in detecting cancer. This technique had been found to diagnose more clinically relevant prostate cancer”.  Read more about the UroNav Fusion Biopsy System from Invivo.

 

How does it all work?

Patients have the MRI at Miami Valley Hospital on a new Tesla 3 or 3T MRI machine, several days to weeks prior to the actual biopsy; which allows for identification of target lesions within the prostate. These images are then imported from the MRI and are over-played on the live prostate ultrasound, in the operating room at Miami Valley South, which allows for a targeted biopsy of the abnormality seen on MRI.

MRI ultrasound fusion guided prostate biopsy is currently recommended for the patient who has a rising PSA despite a prior negative biopsy.   If you think this test might be right for you…talk to your urologist.

 

 At Dayton Physicians Network, we are the leaders in prostate cancer diagnosis and treatment in the Miami Valley, no need to drive out of the area.  We offer all levels of care for patients with any prostate symptoms or prostate cancer. We are experienced; in 2014 we cared for nearly 4,000 patients diagnosed with prostate cancer and many others who were found to be prostate cancer free.

We’re here for you, leading with advanced technology for prostate cancer diagnosis and treatment.